APA (7th ed.) Citation

Fournier M, Chen C, Kuznik A, Proudfoot C, Mallya UG, & Michaud K. (2019). Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: An analysis of incremental cost per effectively treated patient. Dove Medical Press.

Chicago Style (17th ed.) Citation

Fournier M, Chen C, Kuznik A, Proudfoot C, Mallya UG, and Michaud K. Sarilumab Monotherapy Compared with Adalimumab Monotherapy for the Treatment of Moderately to Severely Active Rheumatoid Arthritis: An Analysis of Incremental Cost Per Effectively Treated Patient. Dove Medical Press, 2019.

MLA (9th ed.) Citation

Fournier M, et al. Sarilumab Monotherapy Compared with Adalimumab Monotherapy for the Treatment of Moderately to Severely Active Rheumatoid Arthritis: An Analysis of Incremental Cost Per Effectively Treated Patient. Dove Medical Press, 2019.